New drug therapy could improve brain function and life expectancy of ALS patients

Published: 25/05/2017
New drug therapy could improve brain function and life expectancy of ALS patients
Source: WWW.SCIENCEDAILY.COM

A researcher has successfully redesigned a portion of MabThera, an FDA-approved drug used to treat certain autoimmune diseases and types of cancer, into a new molecule to treat ALS, outlines a new report.

Read more
Related news
Comment